These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39046595)

  • 1. The role of VI-RADS scoring criteria for predicting oncological outcomes in bladder cancer.
    Kozikowski M; Zagrodzka M; Zawadzki M; Zugaj P; Osiecki R; Rzymkowski F; Śledź M; Sosnowski R; Dobruch J; Giudice FD; Krajewski W
    World J Urol; 2024 Jul; 42(1):438. PubMed ID: 39046595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI-based VI-RADS: can it predict 1- to 5-year recurrence of bladder cancer?
    Xu X; Huang Y; Liu Y; Cai Q; Guo Y; Wang H; Lu H
    Eur Radiol; 2024 May; 34(5):3034-3045. PubMed ID: 37926742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Additional MRI-Based Morphologic Measurements on the Performance of VI-RADS for Muscle-Invasive Bladder Cancer.
    Gong Y; Cheng Y; Zhang J; Bao ML; Zhu FP; Sun XY; Zhang YD
    J Magn Reson Imaging; 2024 Sep; 60(3):1113-1123. PubMed ID: 38258496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    Hong SB; Lee NK; Kim S; Son IW; Ha HK; Ku JY; Kim KH; Park WY
    J Magn Reson Imaging; 2020 Oct; 52(4):1249-1256. PubMed ID: 32220105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
    Arita Y; Kwee TC; Woo S; Shigeta K; Ishii R; Okawara N; Edo H; Waseda Y; Vargas HA
    Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesical imaging reporting and data system (VI-RADS) could predict the survival of bladder-cancer patients who received radical cystectomy.
    Zhuang J; Cai L; Sun H; Wu Q; Li K; Yu R; Cao Q; Li P; Yang X; Lu Q
    Sci Rep; 2023 Dec; 13(1):21502. PubMed ID: 38057353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
    Arita Y; Shigeta K; Akita H; Suzuki T; Kufukihara R; Kwee TC; Ishii R; Mikami S; Okuda S; Kikuchi E; Oya M; Jinzaki M
    Eur Radiol; 2021 Feb; 31(2):875-883. PubMed ID: 32829418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
    Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
    AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Woo S; Panebianco V; Narumi Y; Del Giudice F; Muglia VF; Takeuchi M; Ghafoor S; Bochner BH; Goh AC; Hricak H; Catto JWF; Vargas HA
    Eur Urol Oncol; 2020 Jun; 3(3):306-315. PubMed ID: 32199915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L; Wen Z; Cai Q; Lin Y; Chen Y; Cao W; Li M; Qian L; Chen J; Guo Y; Wang H
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
    Ueno Y; Takeuchi M; Tamada T; Sofue K; Takahashi S; Kamishima Y; Hinata N; Harada K; Fujisawa M; Murakami T
    Eur Urol; 2019 Jul; 76(1):54-56. PubMed ID: 30922688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
    Kazan O; Gunduz N; Bakir B; Iplikci A; Culpan M; Ersoy B; Yildirim A
    Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study.
    Marchioni M; Primiceri G; Delli Pizzi A; Basilico R; Berardinelli F; Mincuzzi E; Castellucci R; Sessa B; Di Nicola M; Schips L
    Clin Genitourin Cancer; 2020 Oct; 18(5):409-415.e1. PubMed ID: 32273236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer.
    Elshetry ASF; El-Fawakry RM; Hamed EM; Metwally MI; Zaid NA
    Eur J Radiol; 2022 Jun; 151():110282. PubMed ID: 35381566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion.
    Wang H; Luo C; Zhang F; Guan J; Li S; Yao H; Chen J; Luo J; Chen L; Guo Y
    Radiology; 2019 Jun; 291(3):668-674. PubMed ID: 31012814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.
    Jazayeri SB; Dehghanbanadaki H; Hosseini M; Taghipour P; Alam MU; Balaji KC; Bandyk M
    Urol Oncol; 2022 Feb; 40(2):45-55. PubMed ID: 34895996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Muscular Invasion in Bladder Cancer: Additional Value of Synthetic Magnetic Resonance Imaging.
    Zhang X; Guo J; Yun Y; Shan D; Yang D; Xu C; Chen X
    Acad Radiol; 2024 Oct; 31(10):4076-4084. PubMed ID: 38548534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.